Otago Exercise Programme and Physical Function in Older Adults in Sarawak (OEP)

November 28, 2025 updated by: Anselm Ting Su, University Malaysia Sarawak

Effects of the Otago Exercise Programme on Senior Physical Fitness, Balance, and Quality of Life Among Older Adults in Sarawak: A Randomised Controlled Trial

This randomized controlled trial aims to evaluate the effects of the Otago Exercise Programme (OEP) on physical fitness, balance, and quality of life among older adults in Sarawak, Malaysia. The intervention involves a structured home-based and group-supervised exercise programme focused on lower-limb strength and balance training. A total of 120 community-dwelling older adults aged 60 years and above were recruited from Bau District, Sarawak, and randomized into intervention (OEP) and control groups. The intervention group participated in the OEP for 12 weeks, while the control group maintained their usual activities.

Assessments were conducted at baseline, 6 weeks, and 12 weeks using the Senior Fitness Test (SFT), Berg Balance Scale (BBS), and WHOQOL-BREF to evaluate changes in physical fitness, balance, and quality of life. The study aims to provide evidence on the effectiveness of OEP as a feasible, community-based fall-prevention and functional fitness programme for older adults in Malaysia. Findings will contribute to national healthy ageing policy and rehabilitation strategies under the WHO Decade of Healthy Ageing (2021-2030) framework.

Study Overview

Detailed Description

This study used a two-arm, parallel-group randomized controlled trial design to evaluate the effectiveness of the Otago Exercise Programme (OEP) in improving physical fitness, balance, and functional mobility among community-dwelling older adults in the Bau District of Sarawak, Malaysia.

Participants were screened for eligibility and safety using clinical history, medical clearance forms, and physical readiness questions. Randomization was conducted using computer-generated permuted blocks, with allocation sequences prepared and concealed by an independent coordinator not involved in assessment or intervention delivery.

The intervention protocol followed the standardized OEP training manual and included lower-limb strengthening, balance exercises, functional mobility tasks, and progressive walking prescriptions. Participants performed three weekly home-based sessions supported by weekly group-supervised sessions led by trained facilitators. Exercise progression was individualized according to participant capability and safety guidelines.

Outcome assessments were conducted at baseline, week 6, and week 12 by assessors who were blinded to group allocation. Standardized measurement procedures were used following the Senior Fitness Test (SFT) manual and the Berg Balance Scale (BBS) assessment protocol. Adverse events and training adherence were monitored throughout the intervention period.

The study operated under ethical approval from the Medical Research Ethics Committee, Universiti Malaysia Sarawak (Ref: FME/24/115). This project was conducted as part of a Doctor of Public Health (DrPH) research requirement. Findings are expected to contribute evidence for community-based fall-prevention strategies and healthy ageing programmes in Malaysia.

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sarawak
      • Bau, Sarawak, Malaysia, 94000
        • Dewan Tasik Biru

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Community-dwelling older adults aged 60 to 100 years residing in Bau District, Sarawak.
  • Able to ambulate independently, with or without an assistive device.
  • Physically and cognitively able to participate in exercise sessions.
  • Willing to provide written informed consent and commit to the 12-week programme and all scheduled assessments.
  • Medically cleared for moderate-intensity exercise by a healthcare provider.

Exclusion Criteria:

  • Severe visual, auditory, neurological, or musculoskeletal impairment that limits safe participation in exercise.
  • Unstable medical conditions (e.g., uncontrolled hypertension, recent cardiac event, severe respiratory illness).
  • Cognitive impairment or diagnosed dementia preventing informed participation.
  • Currently participating in any other structured exercise or physiotherapy programme.
  • Any contraindication to moderate-intensity physical activity as determined by screening or medical history.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental: Otago Exercise Programme (OEP)
Participants in the intervention group will receive the Otago Exercise Programme (OEP), a structured, multicomponent home- and group-based exercise programme focusing on lower-limb strength, balance, and functional mobility. Each supervised session lasts about 60 minutes and includes warm-up, strengthening, balance, and cool-down exercises. Sessions are conducted three times weekly for 12 weeks under supervision by trained facilitators, with participants encouraged to continue selected exercises at home.
The Otago Exercise Programme (OEP) is a behavioural, multicomponent exercise protocol focusing on lower-limb strength, balance, and functional mobility. It includes warm-up, strengthening, balance, and cool-down components performed three times weekly for 12 weeks under trained supervision. The programme aims to improve balance, enhance lower-limb strength, and reduce fall risk among community-dwelling older adults.
No Intervention: No Intervention: Usual Daily Activity (Control)
Participants in the control group will continue their usual daily activities and will not participate in any structured exercise programme. They will receive general health education leaflets on physical activity and fall prevention at baseline, without additional supervised training.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Balance performance measured using the Berg Balance Scale (BBS)
Time Frame: Baseline, 6 weeks, and 12 weeks after intervention start
Balance ability will be assessed using the Berg Balance Scale (BBS), a 14-item objective measure designed to evaluate balance in older adults. Each item is scored on a 5-point scale (0-4), with a total possible score of 56. Higher scores indicate better balance and lower fall risk.
Baseline, 6 weeks, and 12 weeks after intervention start

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
30-Second Chair Stand Test Performance
Time Frame: Baseline, 6 weeks, and 12 weeks after intervention start
The 30-second chair stand test will assess lower-body strength. Participants will be instructed to stand up fully and sit down as many times as possible within 30 seconds. Higher scores represent greater lower-body strength.
Baseline, 6 weeks, and 12 weeks after intervention start
Arm Curl Test Performance
Time Frame: Baseline, 6 weeks, and 12 weeks after intervention start
Upper-body strength will be assessed using the Arm Curl Test. Participants will perform as many arm curls as possible in 30 seconds using a standardized dumbbell (5 lbs for women and 8 lbs for men). A higher number of repetitions indicates greater upper-body strength.
Baseline, 6 weeks, and 12 weeks after intervention start
2-Minute Step Test Performance
Time Frame: Baseline, 6 weeks, and 12 weeks after intervention start
Aerobic endurance will be assessed using the 2-minute step test. Participants will march in place for 2 minutes, lifting the knees to a height midway between the patella and iliac crest. The number of steps meeting the required height will be counted. Higher numbers indicate greater aerobic endurance.
Baseline, 6 weeks, and 12 weeks after intervention start
Chair Sit-and-Reach Test Performance
Time Frame: Baseline, 6 weeks, and 12 weeks after intervention start
Flexibility will be assessed using the chair sit-and-reach test. Participants will sit on the edge of a chair with one leg extended and reach toward the toes. The distance reached (positive score for reaching past the toes, negative score if short of toes) will be recorded. Higher values indicate better lower-body flexibility.
Baseline, 6 weeks, and 12 weeks after intervention start
Back Scratch Test Performance
Time Frame: Baseline, 6 weeks, and 12 weeks after intervention start
Upper-body flexibility will be assessed using the back scratch test. Participants will place one hand over the shoulder and the other behind the back, attempting to touch or overlap the middle fingers. The distance between the fingertips (positive score for overlap, negative for gap) will be recorded. Higher values indicate better upper-body flexibility.
Baseline, 6 weeks, and 12 weeks after intervention start
8-Foot Up-and-Go Test Performance
Time Frame: Baseline, 6 weeks, and 12 weeks after intervention start
Agility and dynamic balance will be assessed using the 8-foot up-and-go test. Participants will rise from a seated position, walk 8 feet, turn around, and return to sit down as quickly as possible. The total time taken (in seconds) will be recorded. Shorter times indicate better agility and dynamic balance.
Baseline, 6 weeks, and 12 weeks after intervention start

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life measured using the WHOQOL-BREF questionnaire
Time Frame: Baseline, 6 weeks, and 12 weeks after intervention start
Quality of life will be assessed using the World Health Organization Quality of Life-BREF (WHOQOL-BREF) questionnaire, which consists of 26 items covering four domains: physical health, psychological well-being, social relationships, and environment. Higher domain scores indicate better quality of life.
Baseline, 6 weeks, and 12 weeks after intervention start

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2024

Primary Completion (Actual)

June 30, 2024

Study Completion (Actual)

July 31, 2024

Study Registration Dates

First Submitted

November 17, 2025

First Submitted That Met QC Criteria

November 28, 2025

First Posted (Actual)

December 2, 2025

Study Record Updates

Last Update Posted (Actual)

December 2, 2025

Last Update Submitted That Met QC Criteria

November 28, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • UNIMAS-OEP-2024
  • SELF-FUNDED-DRPH-2024 (Other Grant/Funding Number: Dr Saravanan Muruthamuthu (self-funded DrPH))

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data (IPD) will not be shared because the dataset contains identifiable information related to community-dwelling older adults in Sarawak. Data access is restricted under the Universiti Malaysia Sarawak (UNIMAS) Medical Ethics Committee approval. Only aggregated or anonymized results will be available upon reasonable request to the corresponding author.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Fitness

Clinical Trials on Otago Exercise Programme (OEP)

Subscribe